The AHA commented Sept. 15 on the Centers for Medicare & Medicaid Services calendar year 2026 outpatient prospective payment system and ambulatory surgical center payment system proposed rule. The AHA expressed support for several policies in the rule, including direct supervision requirements for certain cardiac rehabilitation services and removing four measures from the Outpatient Quality Reporting program that were recently finalized for removal from the Inpatient Quality Reporting Program, along with the proposal to offer time extensions for data reporting for facilities experiencing an extraordinary circumstance. Provisions the AHA opposed include reducing payment for all drug administration services furnished in off-campus hospital provider-based departments to the “physician fee schedule-equivalent” rate of 40% of the OPPS payment amount, eliminating the inpatient-only list over three years, weakening the ASC Covered Procedures List standard criteria and general exclusion criteria and accelerating the timeline for clawing back funds from CMS' unlawful policy between CY 2018 and 2022 that harmed certain hospitals participating in the 340B Drug Pricing Program.

Headline
The AHA July 14 urged the Health Resources and Services Administration to revise its estimate of the administrative burden associated with the agency’s…
Headline
The AHA today filed a friend-of-the-court brief supporting the Department of Health and Human Services’ motion to dismiss AbbVie’s lawsuit â€¦
Headline
The Health Resources and Services Administration announced that 340B covered entities purchased $100 billion in outpatient drugs under the federal 340B Drug…
Perspective
Public
As we move into the second half of 2026 and Congress returns to work in Washington, D.C., next week, lawmakers face a list of difficult issues that demand…
Headline
The Centers for Medicare & Medicaid Services July 2 issued a proposed rule that would increase Medicare hospital outpatient prospective payment system…
Headline
Eli Lilly said June 1 it will deny 340B Drug Pricing Program discounts to providers that do not meet its documentation requirements by next week.In a statement…